dienogest has been researched along with Bilateral Headache in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Macìas, G; Mellinger, U; Merki-Feld, GS; Parke, S; Serrani, M | 1 |
Blode, H; Lu, M; Morrison, D; Uddin, A; Zeiler, B; Zeun, S | 1 |
Iwen, A; Lehnert, H | 1 |
Domhardt, R; Ganev, M; Golbs, S; Presl, J; Wisser, KH; Zimmermann, T | 1 |
2 trial(s) available for dienogest and Bilateral Headache
Article | Year |
---|---|
Effects of a combined oral contraceptive containing oestradiol valerate/dienogest on hormone withdrawal-associated symptoms: results from the multicentre, randomised, double-blind, active-controlled HARMONY II study.
Topics: Adult; Contraceptives, Oral, Combined; Double-Blind Method; Estradiol; Ethinyl Estradiol; Female; Headache; Humans; Levonorgestrel; Nandrolone; Pelvic Pain; Substance Withdrawal Syndrome; Young Adult | 2013 |
Pharmacokinetics of an oral contraceptive containing oestradiol valerate and dienogest.
Topics: Adolescent; Adult; Carrier Proteins; Contraceptives, Oral; Drug Administration Schedule; Drug Combinations; Estradiol; Female; Headache; Humans; Middle Aged; Nandrolone; Radioimmunoassay; Sex Hormone-Binding Globulin; Young Adult | 2009 |
2 other study(ies) available for dienogest and Bilateral Headache
Article | Year |
---|---|
[Evaluation of obesity in a 22-year-old female patient].
Topics: Blood Sedimentation; Contraceptives, Oral, Combined; Cushing Syndrome; Dexamethasone; Diagnosis, Differential; Ethinyl Estradiol; Female; Giant Cell Arteritis; Headache; Humans; Hydrocortisone; Nandrolone; Obesity, Morbid; Predictive Value of Tests; Young Adult | 2010 |
Clinical findings with the oral contraceptive combination ethinylestradiol/dienogest in the Czech Republic.
Topics: Adolescent; Adult; Breast Diseases; Contraceptives, Oral, Combined; Cytochrome P-450 CYP1A1; Depression; Drug Administration Schedule; Female; Gastrointestinal Diseases; Headache; Humans; Nandrolone; Prospective Studies; Skin Diseases; Steroid Hydroxylases; Treatment Failure; Treatment Outcome | 2002 |